The Asia Pacific Reishi Mushroom Market is expected to witness market growth of 8.5% CAGR during the forecast period (2022-2028).
They have a modest quantity of fat, protein, and complex carbs as macronutrients. Reishi is abundant in minerals like potassium, zinc, phosphorus, and manganese and also offers vital micronutrients. Additionally, about 400 bioactive substances, including triterpenoids, polysaccharides, nucleotides, steroids, sterols, fatty acids, and proteins/peptides, have been discovered by researchers.
Because wild reishi is so uncommon, it was formerly only given to monarchs and kings. However, this functional mushroom has been successfully grown by mycologists in robust and accessible forms on nutrient-rich substrates like organic oats. Reishi has a mildly bitter flavour but may be used into hot and cold beverages, as well as inventive recipes. It is offered in a variety of forms, including handy capsules and organically grown powders. It is suitable for consumption at any time of day.
Reishi mushrooms contain polysaccharide substances that are beneficial to the immune system in a variety of ways. Reishi affects cellular immunity by stimulating immune cells including macrophages and helper-T cells. Reishi has an impact on humoral immunity by stimulating the production of more immunoglobulin. By encouraging an enhanced immunological response, reishi helps the body's defence against infections including germs and viruses.
One of the world's biggest reishi mushroom growers is China. To suit the high demand on the domestic and international markets, the nation produces mushrooms on a big scale. Reishi is widely utilised in traditional Chinese medicine and is also referred to as the "Elixir of Life" and the "Mushroom of Immortality." As a result, there will likely be a significant rise in the demand for Reishi medicinal mushrooms in Asia-Pacific in the market under study. Reishi mushrooms are also widely utilised as medicine in several nations, including Korea and Japan.
The China market dominated the Asia Pacific Reishi Mushroom Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $574.8 million by 2028. The Japan market is poised to grow at a CAGR of 7.9% during (2022 - 2028). Additionally, The India market is expected to showcase a CAGR of 9.2% during (2022 - 2028).
Based on End Use, the market is segmented into Pharmaceutical, Nutraceutical & Dietary Supplements, Food & Beverages and Cosmetics & Personal Care. Based on Form, the market is segmented into Powder and Liquid. Based on Nature, the market is segmented into Conventional and Organic. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hokkaido Reishi Co. Ltd., Alphay International, Inc., Bio-Botanica, Inc., Bristol Botanicals Limited, Ron Teeguarden Enterprises, Inc., DXN Holdings Bhd., Xi'an Greena Biotech Co., Ltd., Nammex, JHS Natural Products, Inc. (Mushroom Science)
They have a modest quantity of fat, protein, and complex carbs as macronutrients. Reishi is abundant in minerals like potassium, zinc, phosphorus, and manganese and also offers vital micronutrients. Additionally, about 400 bioactive substances, including triterpenoids, polysaccharides, nucleotides, steroids, sterols, fatty acids, and proteins/peptides, have been discovered by researchers.
Because wild reishi is so uncommon, it was formerly only given to monarchs and kings. However, this functional mushroom has been successfully grown by mycologists in robust and accessible forms on nutrient-rich substrates like organic oats. Reishi has a mildly bitter flavour but may be used into hot and cold beverages, as well as inventive recipes. It is offered in a variety of forms, including handy capsules and organically grown powders. It is suitable for consumption at any time of day.
Reishi mushrooms contain polysaccharide substances that are beneficial to the immune system in a variety of ways. Reishi affects cellular immunity by stimulating immune cells including macrophages and helper-T cells. Reishi has an impact on humoral immunity by stimulating the production of more immunoglobulin. By encouraging an enhanced immunological response, reishi helps the body's defence against infections including germs and viruses.
One of the world's biggest reishi mushroom growers is China. To suit the high demand on the domestic and international markets, the nation produces mushrooms on a big scale. Reishi is widely utilised in traditional Chinese medicine and is also referred to as the "Elixir of Life" and the "Mushroom of Immortality." As a result, there will likely be a significant rise in the demand for Reishi medicinal mushrooms in Asia-Pacific in the market under study. Reishi mushrooms are also widely utilised as medicine in several nations, including Korea and Japan.
The China market dominated the Asia Pacific Reishi Mushroom Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $574.8 million by 2028. The Japan market is poised to grow at a CAGR of 7.9% during (2022 - 2028). Additionally, The India market is expected to showcase a CAGR of 9.2% during (2022 - 2028).
Based on End Use, the market is segmented into Pharmaceutical, Nutraceutical & Dietary Supplements, Food & Beverages and Cosmetics & Personal Care. Based on Form, the market is segmented into Powder and Liquid. Based on Nature, the market is segmented into Conventional and Organic. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hokkaido Reishi Co. Ltd., Alphay International, Inc., Bio-Botanica, Inc., Bristol Botanicals Limited, Ron Teeguarden Enterprises, Inc., DXN Holdings Bhd., Xi'an Greena Biotech Co., Ltd., Nammex, JHS Natural Products, Inc. (Mushroom Science)
Scope of the Study
Market Segments Covered in the Report:
By End Use- Pharmaceutical, Nutraceutical & Dietary Supplements
- Food & Beverages
- Cosmetics & Personal Care
- Powder
- Liquid
- Conventional
- Organic
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Hokkaido Reishi Co. Ltd.
- Alphay International, Inc.
- Bio-Botanica, Inc.
- Bristol Botanicals Limited
- Ron Teeguarden Enterprises, Inc.
- DXN Holdings Bhd.
- Xi'an Greena Biotech Co., Ltd.
- Nammex
- JHS Natural Products, Inc. (Mushroom Science)
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Asia Pacific Reishi Mushroom Market by End Use
Chapter 4. Asia Pacific Reishi Mushroom Market by Form
Chapter 5. Asia Pacific Reishi Mushroom Market by Nature
Chapter 6. Asia Pacific Reishi Mushroom Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Hokkaido Reishi Co. Ltd.
- Alphay International, Inc.
- Bio-Botanica, Inc.
- Bristol Botanicals Limited
- Ron Teeguarden Enterprises, Inc.
- DXN Holdings Bhd.
- Xi'an Greena Biotech Co., Ltd.
- Nammex
- JHS Natural Products, Inc. (Mushroom Science)
Methodology
LOADING...
